| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9ASN9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.582 |
| CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.527 |
| CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.555 |
| CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.560 |
| CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.527 |
| CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.639 |
| CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.657 |
| CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.701 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.533 |
| DEG_SCF_FBW7_1 | 19 | 24 | PF00400 | 0.639 |
| DOC_MAPK_gen_1 | 2 | 10 | PF00069 | 0.524 |
| DOC_WW_Pin1_4 | 17 | 22 | PF00397 | 0.570 |
| LIG_14-3-3_CanoR_1 | 11 | 15 | PF00244 | 0.613 |
| LIG_14-3-3_CanoR_1 | 2 | 10 | PF00244 | 0.548 |
| LIG_APCC_ABBA_1 | 94 | 99 | PF00400 | 0.477 |
| LIG_BRCT_BRCA1_1 | 128 | 132 | PF00533 | 0.571 |
| LIG_FHA_1 | 3 | 9 | PF00498 | 0.521 |
| LIG_FHA_2 | 42 | 48 | PF00498 | 0.493 |
| LIG_LIR_Gen_1 | 79 | 86 | PF02991 | 0.496 |
| LIG_LIR_Nem_3 | 79 | 83 | PF02991 | 0.511 |
| LIG_SH2_GRB2like | 40 | 43 | PF00017 | 0.509 |
| LIG_SH2_NCK_1 | 97 | 101 | PF00017 | 0.519 |
| LIG_SH2_SRC | 80 | 83 | PF00017 | 0.570 |
| LIG_SH2_STAT3 | 109 | 112 | PF00017 | 0.490 |
| LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.585 |
| LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.515 |
| MOD_CDK_SPxK_1 | 17 | 23 | PF00069 | 0.637 |
| MOD_CK1_1 | 72 | 78 | PF00069 | 0.465 |
| MOD_CK2_1 | 41 | 47 | PF00069 | 0.494 |
| MOD_GlcNHglycan | 126 | 131 | PF01048 | 0.563 |
| MOD_GSK3_1 | 17 | 24 | PF00069 | 0.614 |
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.468 |
| MOD_GSK3_1 | 41 | 48 | PF00069 | 0.537 |
| MOD_GSK3_1 | 52 | 59 | PF00069 | 0.626 |
| MOD_GSK3_1 | 72 | 79 | PF00069 | 0.410 |
| MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.497 |
| MOD_NEK2_2 | 6 | 11 | PF00069 | 0.488 |
| MOD_PIKK_1 | 10 | 16 | PF00454 | 0.408 |
| MOD_PIKK_1 | 72 | 78 | PF00454 | 0.582 |
| MOD_PKA_1 | 2 | 8 | PF00069 | 0.630 |
| MOD_PKA_2 | 10 | 16 | PF00069 | 0.640 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.591 |
| MOD_Plk_1 | 41 | 47 | PF00069 | 0.494 |
| MOD_Plk_1 | 69 | 75 | PF00069 | 0.496 |
| MOD_ProDKin_1 | 17 | 23 | PF00069 | 0.570 |
| MOD_SUMO_rev_2 | 46 | 50 | PF00179 | 0.503 |
| TRG_DiLeu_BaEn_4 | 69 | 75 | PF01217 | 0.496 |
| TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.469 |
| TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.570 |
| TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.542 |
| TRG_ER_diArg_1 | 64 | 67 | PF00400 | 0.533 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I3V3 | Leptomonas seymouri | 83% | 100% |
| A0A0S4J8Z0 | Bodo saltans | 53% | 100% |
| A0A1X0P9F9 | Trypanosomatidae | 71% | 98% |
| A0A3Q8ING9 | Leishmania donovani | 94% | 100% |
| A4HNX9 | Leishmania braziliensis | 90% | 100% |
| A4ICL5 | Leishmania infantum | 94% | 100% |
| D0A2U5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 80% | 100% |
| Q4Q1V7 | Leishmania major | 93% | 100% |
| V5BUX9 | Trypanosoma cruzi | 71% | 100% |